These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1527264)

  • 41. Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
    Laes JR; Williams DM; Cole JB
    J Med Toxicol; 2015 Dec; 11(4):460-3. PubMed ID: 26310944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
    Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Research progress of methylene blue in the treatment of sepsis and septic shock].
    Xue J; Lou X; Chen G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1384-1387. PubMed ID: 34980315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous infusion of methylene blue for septic shock.
    Brown G; Frankl D; Phang T
    Postgrad Med J; 1996 Oct; 72(852):612-4. PubMed ID: 8977944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
    Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
    Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
    Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
    Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of methylene blue treatment for cardiovascular collapse.
    Lo JC; Darracq MA; Clark RF
    J Emerg Med; 2014 May; 46(5):670-9. PubMed ID: 24508113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
    Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
    Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock.
    Barth E; Radermacher P; Thiemermann C; Weber S; Georgieff M; Albuszies G
    Crit Care Med; 2006 Feb; 34(2):307-13. PubMed ID: 16424707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
    Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
    Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of methylene blue infusion on gastric tonometry and intestinal fatty acid binding protein levels in septic shock patients.
    van Haren FM; Pickkers P; Foudraine N; Heemskerk S; Sleigh J; van der Hoeven JG
    J Crit Care; 2010 Jun; 25(2):358.e1-7. PubMed ID: 20381302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice?
    Viaro F; Dalio MB; Evora PR
    Chest; 2002 Sep; 122(3):1061-6. PubMed ID: 12226053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Septic shock and NO].
    Mitaka C
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():540-3. PubMed ID: 15506445
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance.
    Schreuder WO; Schneider AJ; Groeneveld AB; Thijs LG
    Chest; 1989 Jun; 95(6):1282-8. PubMed ID: 2721267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylene Blue to Neonatal Septic Shock treatment in neonate pigs
    Gonçalves-Ferri WA; Albuquerque AAS; de Castro RSAP; Ferreira CHF; Oharomari LK; Silva Lessa DF; Evora PRB
    Clinics (Sao Paulo); 2022; 77():100139. PubMed ID: 36459779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylene blue in the treatment of vasoplegia following severe burns.
    Jaskille AD; Jeng JC; Jordan MH
    J Burn Care Res; 2008; 29(2):408-10. PubMed ID: 18354304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep.
    Kirov MY; Evgenov OV; Bjertnaes LJ
    Crit Care Med; 2003 Jan; 31(1):179-86. PubMed ID: 12545013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylene Blue for Acute Septic Cardiomyopathy in a Burned Patient.
    Schlesinger JJ; Burger CF
    J Burn Care Res; 2016; 37(3):e287-91. PubMed ID: 25798807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Short term effects of hypertonic saline during severe sepsis and septic shock].
    Muller L; Lefrant JY; Jaber S; Louart G; Mahamat A; Ripart J; de La Coussaye JE; Eledjam JJ
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):575-80. PubMed ID: 15234722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.